Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)

BrightSpring Health Services · Partnership · September 17, 2026

Onco360 entered a partnership with AstraZeneca to serve as a national pharmacy partner for Etcamah (camizestrant), indicated for certain adult patients with advanced or metastatic breast cancer.

Read the announcement

AntSpace’s summary of BrightSpring Health Services’s own announcement: read the original.

More updates from BrightSpring Health Services